Abstract information

Abstract submissions are now open!

The abstract submissions will close on July 17th at 23.59 CET.

Submission guidelines

You should only submit an abstract if you intend to attend the congress. If your abstract is accepted for an oral or poster presentation you must register for the congress. ISBT reserves the right to remove any abstract from publication whose author does not register within two weeks of receipt of the acceptance letter.


Abstract topics for ISBT Cape Town

Abstracts for the Submitted Program will be accepted into the following topics:

1. Management and organisation

1.1    Organisational issues
1.2    Information technology 
1.3    Cost/effectiveness
1.4    Training and education 
1.5    Risk models, standards and regulation
1.6    Blood supply management and utilization
1.7    Quality management
1.8    Vein to vein registries - use of big data - epidemiology 
1.9    Social, legal, ethics blood donation and transfusion

2. Blood donation

2.1    Blood donor recruitment and retention
2.2    Blood donor health
2.3    Blood collection including apheresis
2.4    Donor adverse events
2.5    Blood donor biorepositories and public health research

3. Blood products / components

3.1    Blood processing, storage and release
3.2    Blood components
3.3    Plasma derived products
3.4    Pathogen inactivation
3.5    Novel blood products/components

4. Transfusion transmitted infections

4.1    Screening strategies for TTI
4.2    Hepatitis B (HBV)
4.3    Hepatitis C (HCV)
4.4    HIV
4.5    Bacteria
4.6    Parasites
4.7    Newly emerging pathogens and other transfusion related pathogens

5. Immunohaematology

5.1    Red cell immunohaematology: serology
5.2    Red cell immunohaematology: molecular
5.3    Rare Donors
5.4    Platelet immunology
5.5    Granulocyte immunology
5.6    Fetal-maternal immunology

6. Clinical Transfusion

6.1    Neonatal and pediatric transfusion
6.2    Therapeutic apheresis
6.3    Evidence based transfusion medicine practice
6.4    Haemorrhage and massive transfusion
6.5    Adverse events, including TRALI
6.6    Haemovigilance and patient safety
6.7    Alternatives to blood transfusion
6.8    Patient Blood Management (PBM)
6.9    Clinical / laboratory interface - Transfusion Practitioner (TP) initiatives

7. Cellular therapies

7.1    Stem cell and tissue banking, including cord blood 
7.2    Collection, processing, storage and release
7.3    Clinical applications
7.4    Histocompatibility in stem cell transplantation

8. Clinical immunogenetics

8.1    HLA in transfusion medicine
8.2    Histocompatibility in stem cell transplantation
8.3    Histocompatibility in +A1:B55organ transplantation